ZEN Graphene Solutions to Present at the Benzinga Global Small Cap Conference

Guelph, ON

ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSX-V: ZEN and OTC: ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces today that Chief Executive Officer, Greg Fenton will present a corporate overview at the Benzinga Global Small Cap Conference, which is being held virtually on October 27 – 28, 2021.

Mr. Fenton will deliver his corporate presentation on Wednesday, October 27 at 3:00 PM ET.

Mr. Fenton will be available for one-on-one meetings throughout the conference.

Register for the conference HERE

  • Share

About Zentek Ltd.

Zentek is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment. Zentek is currently focused on commercializing ZENGuard™, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.

To find out more about Zentek Ltd., please visit our website at www.zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR profile at www.sedar.com.

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Matt Blazei

CORE IR

(212) 655-0924

mattb@coreir.com

Subscribe for Updates

Interested in recieving press releases directly to your inbox? Subscribe to Zentek's mailing list for all the latest news.